A Novel Schlemm's Canal Scaffold

Histologic Observations

Ian Grierson, Hady Saheb, Malik Y. Kahook, Murray A. Johnstone, Iqbal I K Ahmed, Andrew T. Schieber, Carol B Toris

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Purpose: To assess the biocompatibility of a novel implant made of Nitinol (nickel-titanium alloy), designed to improve aqueous humor outflow. Materials and Methods: In the first arm of biocompatibility testing, microstents were surgically inserted into Schlemm's canal (SC) of 2 non-human primates (NHPs), and a third NHP served as a surgical sham control. After 13 weeks the animals were killed, and the eyes were examined by light and scanning electron microscopy. Two masked investigators evaluated the histology sections. The second arm utilized 8 New Zealand white rabbits; each rabbit received a microstent inserted into the sclera and subconjunctival space by means of passage across the anterior chamber thus providing contact with several representative ocular tissues. The fellow eye of each rabbit underwent a sham procedure without microstent insertion. The rabbits were killed after 26 weeks, and a trained ocular pathologist examined the specimens using light microscopy. Results: Histologic and scanning electron microscopy analysis of the NHPs demonstrated that the microstents were located in SC. There was no evidence of an acute or chronic inflammatory response, granulation response, or fibrosis in the outflow system or in adjacent tissues. Rabbit eyes showed minimal mononuclear cell infiltration and minimal fibrotic responses at the site of the implants when compared with sham-treated control eyes. Conclusions: The Hydrus Microstent was associated with minimal inflammation in both NHP and rabbit eyes with extended follow-up. These preclinical studies demonstrate that the Hydrus Microstent appears to have excellent long-term biocompatibility.

Original languageEnglish (US)
Pages (from-to)460-468
Number of pages9
JournalJournal of Glaucoma
Volume24
Issue number6
DOIs
StatePublished - Aug 19 2015
Externally publishedYes

Fingerprint

Rabbits
Primates
Electron Scanning Microscopy
Arm
Materials Testing
Light
Sclera
Aqueous Humor
Anterior Chamber
Microscopy
Histology
Fibrosis
Research Personnel
Inflammation
nitinol

Keywords

  • drainage device
  • glaucoma
  • human
  • IOP
  • MIGS
  • Schlemm's canal
  • trabecular meshwork

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Grierson, I., Saheb, H., Kahook, M. Y., Johnstone, M. A., Ahmed, I. I. K., Schieber, A. T., & Toris, C. B. (2015). A Novel Schlemm's Canal Scaffold: Histologic Observations. Journal of Glaucoma, 24(6), 460-468. https://doi.org/10.1097/IJG.0000000000000012

A Novel Schlemm's Canal Scaffold : Histologic Observations. / Grierson, Ian; Saheb, Hady; Kahook, Malik Y.; Johnstone, Murray A.; Ahmed, Iqbal I K; Schieber, Andrew T.; Toris, Carol B.

In: Journal of Glaucoma, Vol. 24, No. 6, 19.08.2015, p. 460-468.

Research output: Contribution to journalArticle

Grierson, I, Saheb, H, Kahook, MY, Johnstone, MA, Ahmed, IIK, Schieber, AT & Toris, CB 2015, 'A Novel Schlemm's Canal Scaffold: Histologic Observations', Journal of Glaucoma, vol. 24, no. 6, pp. 460-468. https://doi.org/10.1097/IJG.0000000000000012
Grierson I, Saheb H, Kahook MY, Johnstone MA, Ahmed IIK, Schieber AT et al. A Novel Schlemm's Canal Scaffold: Histologic Observations. Journal of Glaucoma. 2015 Aug 19;24(6):460-468. https://doi.org/10.1097/IJG.0000000000000012
Grierson, Ian ; Saheb, Hady ; Kahook, Malik Y. ; Johnstone, Murray A. ; Ahmed, Iqbal I K ; Schieber, Andrew T. ; Toris, Carol B. / A Novel Schlemm's Canal Scaffold : Histologic Observations. In: Journal of Glaucoma. 2015 ; Vol. 24, No. 6. pp. 460-468.
@article{ac26caee75ca44bebb830b0b5af52660,
title = "A Novel Schlemm's Canal Scaffold: Histologic Observations",
abstract = "Purpose: To assess the biocompatibility of a novel implant made of Nitinol (nickel-titanium alloy), designed to improve aqueous humor outflow. Materials and Methods: In the first arm of biocompatibility testing, microstents were surgically inserted into Schlemm's canal (SC) of 2 non-human primates (NHPs), and a third NHP served as a surgical sham control. After 13 weeks the animals were killed, and the eyes were examined by light and scanning electron microscopy. Two masked investigators evaluated the histology sections. The second arm utilized 8 New Zealand white rabbits; each rabbit received a microstent inserted into the sclera and subconjunctival space by means of passage across the anterior chamber thus providing contact with several representative ocular tissues. The fellow eye of each rabbit underwent a sham procedure without microstent insertion. The rabbits were killed after 26 weeks, and a trained ocular pathologist examined the specimens using light microscopy. Results: Histologic and scanning electron microscopy analysis of the NHPs demonstrated that the microstents were located in SC. There was no evidence of an acute or chronic inflammatory response, granulation response, or fibrosis in the outflow system or in adjacent tissues. Rabbit eyes showed minimal mononuclear cell infiltration and minimal fibrotic responses at the site of the implants when compared with sham-treated control eyes. Conclusions: The Hydrus Microstent was associated with minimal inflammation in both NHP and rabbit eyes with extended follow-up. These preclinical studies demonstrate that the Hydrus Microstent appears to have excellent long-term biocompatibility.",
keywords = "drainage device, glaucoma, human, IOP, MIGS, Schlemm's canal, trabecular meshwork",
author = "Ian Grierson and Hady Saheb and Kahook, {Malik Y.} and Johnstone, {Murray A.} and Ahmed, {Iqbal I K} and Schieber, {Andrew T.} and Toris, {Carol B}",
year = "2015",
month = "8",
day = "19",
doi = "10.1097/IJG.0000000000000012",
language = "English (US)",
volume = "24",
pages = "460--468",
journal = "Journal of Glaucoma",
issn = "1057-0829",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - A Novel Schlemm's Canal Scaffold

T2 - Histologic Observations

AU - Grierson, Ian

AU - Saheb, Hady

AU - Kahook, Malik Y.

AU - Johnstone, Murray A.

AU - Ahmed, Iqbal I K

AU - Schieber, Andrew T.

AU - Toris, Carol B

PY - 2015/8/19

Y1 - 2015/8/19

N2 - Purpose: To assess the biocompatibility of a novel implant made of Nitinol (nickel-titanium alloy), designed to improve aqueous humor outflow. Materials and Methods: In the first arm of biocompatibility testing, microstents were surgically inserted into Schlemm's canal (SC) of 2 non-human primates (NHPs), and a third NHP served as a surgical sham control. After 13 weeks the animals were killed, and the eyes were examined by light and scanning electron microscopy. Two masked investigators evaluated the histology sections. The second arm utilized 8 New Zealand white rabbits; each rabbit received a microstent inserted into the sclera and subconjunctival space by means of passage across the anterior chamber thus providing contact with several representative ocular tissues. The fellow eye of each rabbit underwent a sham procedure without microstent insertion. The rabbits were killed after 26 weeks, and a trained ocular pathologist examined the specimens using light microscopy. Results: Histologic and scanning electron microscopy analysis of the NHPs demonstrated that the microstents were located in SC. There was no evidence of an acute or chronic inflammatory response, granulation response, or fibrosis in the outflow system or in adjacent tissues. Rabbit eyes showed minimal mononuclear cell infiltration and minimal fibrotic responses at the site of the implants when compared with sham-treated control eyes. Conclusions: The Hydrus Microstent was associated with minimal inflammation in both NHP and rabbit eyes with extended follow-up. These preclinical studies demonstrate that the Hydrus Microstent appears to have excellent long-term biocompatibility.

AB - Purpose: To assess the biocompatibility of a novel implant made of Nitinol (nickel-titanium alloy), designed to improve aqueous humor outflow. Materials and Methods: In the first arm of biocompatibility testing, microstents were surgically inserted into Schlemm's canal (SC) of 2 non-human primates (NHPs), and a third NHP served as a surgical sham control. After 13 weeks the animals were killed, and the eyes were examined by light and scanning electron microscopy. Two masked investigators evaluated the histology sections. The second arm utilized 8 New Zealand white rabbits; each rabbit received a microstent inserted into the sclera and subconjunctival space by means of passage across the anterior chamber thus providing contact with several representative ocular tissues. The fellow eye of each rabbit underwent a sham procedure without microstent insertion. The rabbits were killed after 26 weeks, and a trained ocular pathologist examined the specimens using light microscopy. Results: Histologic and scanning electron microscopy analysis of the NHPs demonstrated that the microstents were located in SC. There was no evidence of an acute or chronic inflammatory response, granulation response, or fibrosis in the outflow system or in adjacent tissues. Rabbit eyes showed minimal mononuclear cell infiltration and minimal fibrotic responses at the site of the implants when compared with sham-treated control eyes. Conclusions: The Hydrus Microstent was associated with minimal inflammation in both NHP and rabbit eyes with extended follow-up. These preclinical studies demonstrate that the Hydrus Microstent appears to have excellent long-term biocompatibility.

KW - drainage device

KW - glaucoma

KW - human

KW - IOP

KW - MIGS

KW - Schlemm's canal

KW - trabecular meshwork

UR - http://www.scopus.com/inward/record.url?scp=84939565474&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939565474&partnerID=8YFLogxK

U2 - 10.1097/IJG.0000000000000012

DO - 10.1097/IJG.0000000000000012

M3 - Article

VL - 24

SP - 460

EP - 468

JO - Journal of Glaucoma

JF - Journal of Glaucoma

SN - 1057-0829

IS - 6

ER -